Mastrobattista E - Search Results

1

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.

Wilbie D, Walther J, Mastrobattista E. Wilbie D, et al. Among authors: mastrobattista e. Acc Chem Res. 2019 Jun 18;52(6):1555-1564. doi: 10.1021/acs.accounts.9b00106. Epub 2019 May 17. Acc Chem Res. 2019. PMID: 31099553 Free PMC article.

2

Trends in polymeric delivery of nucleic acids to tumors.

Yousefi A, Storm G, Schiffelers R, Mastrobattista E. Yousefi A, et al. Among authors: mastrobattista e. J Control Release. 2013 Sep 10;170(2):209-18. doi: 10.1016/j.jconrel.2013.05.040. Epub 2013 Jun 11. J Control Release. 2013. PMID: 23770011 Review.

3

Decationized polyplexes for gene delivery.

Novo L, Mastrobattista E, van Nostrum CF, Lammers T, Hennink WE. Novo L, et al. Among authors: mastrobattista e. Expert Opin Drug Deliv. 2015 Apr;12(4):507-12. doi: 10.1517/17425247.2015.988136. Epub 2014 Nov 26. Expert Opin Drug Deliv. 2015. PMID: 25425332

4

CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.

Oude Blenke E, Evers MJ, Mastrobattista E, van der Oost J. Oude Blenke E, et al. Among authors: mastrobattista e. J Control Release. 2016 Dec 28;244(Pt B):139-148. doi: 10.1016/j.jconrel.2016.08.002. Epub 2016 Aug 4. J Control Release. 2016. PMID: 27498021 Review.

5

Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging.

Beztsinna N, de Matos MBC, Walther J, Heyder C, Hildebrandt E, Leneweit G, Mastrobattista E, Kok RJ. Beztsinna N, et al. Among authors: mastrobattista e. Sci Rep. 2018 Feb 9;8(1):2768. doi: 10.1038/s41598-018-20915-y. Sci Rep. 2018. PMID: 29426932 Free PMC article.

6

Impact of Formulation Conditions on Lipid Nanoparticle Characteristics and Functional Delivery of CRISPR RNP for Gene Knock-Out and Correction.

Walther J, Wilbie D, Tissingh VSJ, Öktem M, van der Veen H, Lou B, Mastrobattista E. Walther J, et al. Among authors: mastrobattista e. Pharmaceutics. 2022 Jan 17;14(1):213. doi: 10.3390/pharmaceutics14010213. Pharmaceutics. 2022. PMID: 35057110 Free PMC article.

7

Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells.

Douka S, Brandenburg LE, Casadidio C, Walther J, Garcia BBM, Spanholtz J, Raimo M, Hennink WE, Mastrobattista E, Caiazzo M. Douka S, et al. Among authors: mastrobattista e. J Control Release. 2023 Sep;361:455-469. doi: 10.1016/j.jconrel.2023.08.014. Epub 2023 Aug 14. J Control Release. 2023. PMID: 37567506 Free article.

8

Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.

Walther J, Porenta D, Wilbie D, Seinen C, Benne N, Yang Q, de Jong OG, Lei Z, Mastrobattista E. Walther J, et al. Among authors: mastrobattista e. Eur J Pharm Biopharm. 2024 Mar;196:114207. doi: 10.1016/j.ejpb.2024.114207. Epub 2024 Feb 6. Eur J Pharm Biopharm. 2024. PMID: 38325664 Free article.

9

The nuclear pore complex: the gateway to successful nonviral gene delivery.

van der Aa MA, Mastrobattista E, Oosting RS, Hennink WE, Koning GA, Crommelin DJ. van der Aa MA, et al. Among authors: mastrobattista e. Pharm Res. 2006 Mar;23(3):447-59. doi: 10.1007/s11095-005-9445-4. Epub 2006 Mar 15. Pharm Res. 2006. PMID: 16525863 Review.

10

Junk DNA enhances pEI-based non-viral gene delivery.

van Gaal EV, Oosting RS, Hennink WE, Crommelin DJ, Mastrobattista E. van Gaal EV, et al. Among authors: mastrobattista e. Int J Pharm. 2010 May 5;390(1):76-83. doi: 10.1016/j.ijpharm.2009.08.032. Epub 2009 Aug 29. Int J Pharm. 2010. PMID: 19720124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page